Shanghai Ziyuan Pharmaceutical is a Shanghai-based pharmaceutical company with an independent manufacturing licence for drugs and medicines. It is good manufactured practice (GMP) certified from the State Food and Drug Administration as well as a current GMP from the Food and Drug Administration (FDA) in the United States of America.
The company manufactures various products and drugs including dobutamine hydrochloride , ethylenediamine diaceturate, calcium cibutyacyladenosine cyclosphate, diisopropylamine dichloroacetate, and more. The drugs have uses such as
Two of its newer products are chlorothiazide and naftifine hydrochloride, which can be used a diuretic and antifungal, respectively. They are both registered in and exported to the United States. The company also works with
Documentaries, videos and podcasts
- Cluster: COVID-19A cluster of topics related to COVID-19. COVID-19 is the abbreviated name for coronavirus disease 2019, a respiratory disease caused by a novel coronavirus strain called SARS-CoV-2. COVID-19 was first detected in Wuhan City, China and the outbreak was declared a pandemic on March 11, 2020 by the WHO.